[ad_1]
SK Life Science, the U.S. subsidiary of SK Biopharm, introduced on Nov. 24 that it’s going to current 10 research together with analysis on major generalized tonic-clonic seizures (PGTC) associated to the epilepsy drug ‘cenobamate’ and maintain a symposium on the ‘2025 American Epilepsy Society (AES) Annual Assembly’ to be held in Atlanta, United States from the fifth to ninth of subsequent month.
At this convention, a Section 3 scientific examine concentrating on PGTC sufferers amongst adolescents and adults has been chosen as a late-breaking summary (LBA) for presentation.
The presentation will likely be primarily based on the generalized seizure scientific topline outcomes that SK Biopharm disclosed final September, and the corporate defined that it’s going to function proof demonstrating cenobamate’s potential as a broad-spectrum antiseizure drug.
Medical outcomes for the oral suspension, a brand new formulation of cenobamate which is at present out there as an oral pill, may even be introduced.
The examine contains outcomes proving that the relative bioavailability between tablets and suspension is analogous and could be administered no matter meals consumption. SK Biopharm plans to submit a New Drug Software (NDA) for the oral suspension formulation inside this 12 months.
The corporate said that pharmacokinetic (PK) evaluation outcomes for partial seizure sufferers aged 12-18 years confirmed drug publicity just like grownup accredited doses, planning to current proof for the potential of indication growth to sufferers aged 12 and above.
SK Life Science will maintain a symposium on the occasion beneath the theme ‘Illuminating New Pathways for Seizure Discount’ to spotlight the evolution of drug-resistant epilepsy remedy and the position of third-generation antiseizure medication.
Sunita Misra, Vice President of World Medical Growth and Medical Affairs at SK Life Science, stated, “This AES 2025 is a chance to clinically affirm cenobamate’s potential for treating generalized seizures and to discover revolutionary instructions in epilepsy remedy along with world consultants,” including, “Via new scientific knowledge associated to cenobamate, we’ll current the potential of new remedy choices to each medical professionals and sufferers.”
[ad_2]
